Literature DB >> 9753713

Attitudes of patients with amyotrophic lateral sclerosis and their care givers toward assisted suicide.

L Ganzini1, W S Johnston, B H McFarland, S W Tolle, M A Lee.   

Abstract

BACKGROUND AND METHODS: Amyotrophic lateral sclerosis (ALS) is a neuromuscular disease that causes gradual paralysis, respiratory failure, and death, usually within three to five years after it has been diagnosed. Between 1995 and 1997, we surveyed patients with this disease in Oregon and Washington, as well as their family care givers, in order to determine their attitudes toward assisted suicide. Patients were considered to be willing to contemplate assisted suicide if they agreed with the statement, "Under some circumstances I would consider taking a prescription for a medicine whose sole purpose was to end my life," and disagreed with the statement, "I would never request or take a prescription for a medication whose sole purpose was to end my life." The Oregon Death with Dignity Act, which legalized physician-assisted suicide, was approved by Oregon voters in 1994 but did not go into effect until October 1997, after data collection for this study had been completed.
RESULTS: Of 140 eligible persons with ALS, 100 (71 percent) agreed to participate in the study, as did 91 family care givers. The mean age of the patients with ALS was 54 years; the mean duration of illness since the diagnosis was 2.8 years. Fifty-six patients (56 percent) said they would consider assisted suicide, and 44 of the 56 agreed with the statement, "If physician-assisted suicide were legal, I would request a lethal prescription from a physician." One patient would have taken the medication immediately, and 36 would have kept it for future use. As compared with the patients who were opposed to assisted suicide, those who would consider it were more likely to be men, had a higher level of education, were less likely to be religious, had higher scores for hopelessness, and rated their quality of life as lower. In 66 of 91 instances (73 percent), care givers and patients had the same attitude toward assisted suicide.
CONCLUSIONS: In Oregon and Washington, a majority of persons with ALS whom we surveyed would consider assisted suicide. Many would request a prescription for a lethal dose of medication well before they intended to use it.

Entities:  

Keywords:  Death and Euthanasia; Empirical Approach

Mesh:

Year:  1998        PMID: 9753713     DOI: 10.1056/NEJM199810013391406

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  35 in total

1.  Recent advances. Medical ethics.

Authors:  P A Singer
Journal:  BMJ       Date:  2000-07-29

2.  Is there such a thing as a life not worth living?

Authors:  B Farsides; R J Dunlop
Journal:  BMJ       Date:  2001-06-16

Review 3.  Introduction to the minireviews series on mitochondrial matters in amyotrophic lateral sclerosis, Lou Gehrig’s disease.

Authors:  George H Sack
Journal:  J Bioenerg Biomembr       Date:  2011-12       Impact factor: 2.945

4.  A cross sectional study on determinants of quality of life in ALS.

Authors:  A Chiò; A Gauthier; A Montuschi; A Calvo; N Di Vito; P Ghiglione; R Mutani
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-11       Impact factor: 10.154

5.  Using literature and innovative assessments to ignite interest and cultivate critical thinking skills in an undergraduate neuroscience course.

Authors:  Eileen Lynd-Balta
Journal:  CBE Life Sci Educ       Date:  2006       Impact factor: 3.325

6.  Measuring depression at the end of life: is the Hamilton Depression Rating Scale a valid instrument?

Authors:  Megan Olden; Barry Rosenfeld; Hayley Pessin; William Breitbart
Journal:  Assessment       Date:  2008-08-01

7.  How California Prepared for Implementation of Physician-Assisted Death: A Primer.

Authors:  Laura A Petrillo; Elizabeth Dzeng; Krista L Harrison; Lindsay Forbes; Benjamin Scribner; Barbara A Koenig
Journal:  Am J Public Health       Date:  2017-04-20       Impact factor: 9.308

8.  Cognitive impairment, behavioral impairment, depression, and wish to die in an ALS cohort.

Authors:  Judith Rabkin; Raymond Goetz; Jennifer Mary Murphy; Pam Factor-Litvak; Hiroshi Mitsumoto
Journal:  Neurology       Date:  2016-08-05       Impact factor: 9.910

9.  Development and psychometric evaluation of a new tool for measuring the attitudes of patients with progressive neurological diseases to ethical aspects of end-of-life care.

Authors:  Radka Bužgová; Radka Kozáková
Journal:  BMC Med Ethics       Date:  2020-04-15       Impact factor: 2.652

10.  Depression and wish to die in a multicenter cohort of ALS patients.

Authors:  Judith G Rabkin; Raymond Goetz; Pam Factor-Litvak; Jonathan Hupf; Martin McElhiney; Jessica Singleton; Hiroshi Mitsumoto
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2014-12-08       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.